Exact Sciences' Blood Test Shows Superior Results in Detecting Early-Stage Liver Cancer Compared to Ultrasound

Exact Sciences Corp.'s Oncoguard Liver blood test outperforms ultrasound in detecting early-stage liver cancer, detecting three times more cancers and demonstrating superior sensitivity at very early stages. The test has 82% specificity and addresses long-standing challenges of ultrasound. The company's Chief Medical Officer called it a "game changer" for accessibility and equity in screening.